|
Volumn 45, Issue 4, 2005, Pages 524-527
|
New drugs: exenatide, pramlintide acetate, and micafungin sodium.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMYLOID;
ANTIDIABETIC AGENT;
ANTIFUNGAL AGENT;
CYCLOPEPTIDE;
EXENDIN 4;
LIPOPROTEIN;
MICAFUNGIN;
PEPTIDE;
PRAMLINTIDE;
VENOM;
ARTICLE;
CANDIDIASIS;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DRUG LABELING;
DRUG STORAGE;
ESOPHAGUS DISEASE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
METHODOLOGY;
MICROBIOLOGY;
SUBCUTANEOUS DRUG ADMINISTRATION;
AMYLOID;
ANTIFUNGAL AGENTS;
CANDIDIASIS;
CLINICAL TRIALS;
DRUG LABELING;
DRUG STORAGE;
ESOPHAGEAL DISEASES;
HUMANS;
HYPOGLYCEMIC AGENTS;
INFUSIONS, INTRAVENOUS;
INJECTIONS, SUBCUTANEOUS;
LIPOPROTEINS;
PEPTIDES;
PEPTIDES, CYCLIC;
VENOMS;
|
EID: 33645969478
PISSN: 15443191
EISSN: None
Source Type: Journal
DOI: 10.1331/1544345054475504 Document Type: Article |
Times cited : (4)
|
References (0)
|